Copyright 1999 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: Our concerns regarding the article
by Dr Backonja and colleagues1 on gabapentin
for treatment of painful diabetic neuropathy are related to how data on patient
interpretation and recording of pain are statistically analyzed, as well as
how clinical rather than statistical significance of improvement on pain scores
Schiebel NEE, Ebbert J. Gabapentin for Painful Diabetic Neuropathy. JAMA. 1999;282(2):133-134. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714